LCMT1 and osteoporosis: Na-DHA may increase osteoporosis risk by upregulating LCMT1, downregulating ARHGEF11 and VCAM1, and disrupting lipid metabolism and the balance between osteogenesis and adipogenesis, ultimately disrupting bone metabolic homeostasis.